OM:BONEXBiotechs
Assessing Bonesupport Holding’s Valuation After Strong Q4 2025 Update And 2026 Growth Outlook
Bonesupport Holding (OM:BONEX) shares are back in focus after the company issued preliminary fourth quarter 2025 figures, indicating 36% net sales growth to 313 MSEK and providing guidance for sales growth above 35% for 2026.
See our latest analysis for Bonesupport Holding.
The preliminary Q4 2025 update came after a mixed share price run, with a 7 day share price return of 14.18% and a 30 day gain of 18.21% contrasting with a 90 day share price decline of 17.90% and a 1 year total...